Start of main content

Pharma & Life Sciences | Newsletter February 2024

| Publications | Pharma & Life Sciences

First edition of Andersen Iberia's Pharma & Life Sciences Newsletter with the main news on legislation, compliance, labour, tax and industrial and intellectual property in the sector

In the first edition of Andersen Iberia’s Pharma & Life Sciences Newsletter, we have collected the main news on legislation, compliance, labor, tax and industrial and intellectual property in the sector.

Aware of the importance that the Pharma & Lifesciences sector has in our economy, at Andersen Iberia we have formed a homogeneous group of top professionals who know the industry to perfection and who can cover all the needs of companies linked to this industry.


-The substantive reform of EU pharmaceutical regulation, Juan Ignacio Alonso

-Criminal liability of the legal entity in the pharmaceutical sector, María Victoria Vega and Esmeralda Iranzo

-Review of obligations to be fulfilled by companies in 2024, Victoria Caldevilla

-The need to review the implementation of technologies for the use of biometric data for time and attendance or access control, María Suárez

-Parallel imports of medicines: repackaged or relabelled?, José Garrido

-The creation of the European Health Data Space as a driver of innovation, Isabel Martínez

-VAT on the transfer of vehicles to employees, Jesús Alemany

You can read the full magazine here.

End of main content